The global contract development service market is anticipated to grow at a CAGR of around 15.2% during the forecast period 2020 to 2027 and to reach around US$ 4.4 Bn by 2027.
Market Dynamics
Increasing government spending by the government on development of healthcare infrastructure, rise in number of clinical trials across the globe, and players approach towards outsourcing the activities are major factor expected to drive the growth of global market. In addition, increasing government focus on development of biologics medicines in order to enhance the treatment of various diseases
According to Avalere Health for the Biosimilars Council shows that 1.2 million U.S. patients could gain access to biologics by 2025 as the result of biosimilar availability. More than 200 biologic products are now approved for use in the United States. Sales of these biologics have increased 65 percent since 2011, reaching more than $105 billion in 2016, as a variety of new biologic treatments for autoimmune disorders, immunology and cancer are entering the market.
Moreover following factors are expected to augment the growth of target market.
In 2020, Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO) signed a contract to advance developmen cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD). The contract was worth US$ 46.3 Mn and is expected to help the company to enhance the business presence.
In 2020, WuXi Biologics a global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing entered into a collaboration with Vir Biotechnology, Inc. for the development & manufacturing of human monoclonal antibodies for the potential treatment of COVID-19. This is expected to help the company to enhance the business.
In 2020, the company finalized the acquisition with Bayer Company for a drug product manufacturing plant in Leverkusen, Germany. This acquisition is expected to help the company to enhance the business presence.
In 2019, WuXi Vaccines a subsidiary of WuXi Biologics that is engaged in human vaccine Contract Development and Manufacturing Organization (CDMO) business invested US$ 240 Mn for the manufacturing of new vaccine facility in Ireland. This investment follows the 20-year manufacturing Letter of Intent (LOI) signed by WuXi Vaccines earlier this year.
In 2019, Samsung BioLogics signed a Contract Development Organization (CDO) contract for immunochemotherapy with GI Innovation. This is expected to help the company to enhance the product portfolio and increase the revenue share.
Rising number of patients suffering from chronic diseases, increasing in clinical testing and developing regulatory scenario in emerging economies are among other factors expected to boost the growth of target market.
However, factors such as high cost associated to R&D and issues related to intellectual property rights are expected to hamper the growth of global contract development service market. In addition, stringent government regulation and lack of advanced infrastructure in developing countries are factors expected to challenge the growth of target market.
Increasing biologics R&D activities by major players and growing product pipelines are factors expected to create new opportunities for players operating in the target market over the forecast period. In addition, high investment by major players and increased spending on infrastructure development is expected to revenue support the growth of target market.
Segment Analysis by Region
The market in Asia Pacific is expected to witness faster growth in the target market due to developing healthcare sector. Government is spending high on infrastructure development with the focus to increase the R&D capabilities. With the availability of favorable business policies in the region, there are emergences of small and mid-size enterprises.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
|
Market
|
Global Contract Development Service Market
|
|
Analysis Period
|
2016 – 2027
|
|
Base Year
|
2019
|
|
Forecast Data
|
2020 – 2027
|
|
Market Stratification
|
Source, Product Service, Product, Disease and Geography
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
|
Contract Development Service Market Segment Analysis, 2019
The global market is segmented into source, product service, product and disease. The source segment is bifurcated into Microbial, Mammalian, and Others. Among the source segment the mammalian segment is expected to account for major revenue share due to increasing use of mammalian cells for protein expression.
The disease segment is divided into oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others. Among the disease segment, the oncology segment is expected to account for major revenue share due to increasing R&D activities and development of novel products.
The players profiled in the report are Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, SE Thermo Fisher, LakePharma, Genscript Biotech Corporation, Bionova Scientific, WuXi Biologics, Boehringer Ingelheim BioXcellence, and STC Biologics, Inc.
Market Segmentation
Market By Source
Microbial
Mammalian
Others
Market By Product Service
Cell Line Development
Process Development
Market By Product
MABs
Recombinant proteins
Others
Market By Diseases
Oncology
Immunological disorders
Cardiovascular disorders
Hematological disorders
Others
Market By Region
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Chapter 1. Industry Overview of Contract Development Service
1.1 Definition and Scope
1.1.1 Definition of Contract Development Service
1.1.2 Market Segmentation
1.1.3 Years Considered for the Study
1.1.4 Assumptions and Acronyms Used
1.1.4.1 Market Assumptions and Market Forecast
1.1.4.2 Acronyms Used In Global Contract Development Service Market
1.2 Summary
1.2.1 Executive Summery
1.2.2 Contract Development Service Market By Source
1.2.3 Global Contract Development Service Market By Product Service
1.2.4 Global Contract Development Service Market By Product
1.2.5 Global Contract Development Service Market By Disease
1.2.6 Global Contract Development Service Market by Regions
Chapter 2. Research Approach
2.1 Methodology
2.1.1 Research Programs/By Product
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
Chapter 3. Market Dynamics and Competition Analysis
3.1 Market Drivers
3.1.1 Driver 1
3.1.2 Driver 2
3.2 Restraints and Challenges
3.2.1 Restraint 1
3.2.2 Restraint 2
3.3 Growth Opportunities
3.3.1 Opportunity 1
3.3.2 Opportunity 2
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitute
3.4.4 Threat of New Entrants
3.4.5 Degree of Competition
3.5 Value Chain Analysis
3.6 Cost Structure Analysis
3.6.1 Proportion of Manufacturing Cost Structure
3.6.1.1 Raw Material
3.6.1.2 Labor Cost
3.6.1.3 Manufacturing Expense
3.7 Regulatory Compliance
3.8 Competitive Landscape, 2019
3.8.1 Player Positioning Analysis
3.8.2 Key Strategies Adopted By Leading Players
Chapter 4. Contract Development Service Market By Source
4.1 Introduction
4.2 Global Contract Development Service Revenue (US$ Mn) by Source
4.2.1 Global Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 – 2027
4.2.2 Microbial
4.2.2.1 Microbial Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.3 Mammalian
4.2.3.1 Mammalian Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.4 Others
4.2.4.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.3 Market Attractive Analysis By Source 2019
Chapter 5. Contract Development Service Market By Product Service
5.1 Introduction
5.2 Global Contract Development Service Revenue (US$ Mn) by Product Service
5.2.1 Global Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 – 2027
5.2.2 Cell Line Development
5.2.2.1 Cell Line Development Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3 Process Development
5.2.3.1 Process Development Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.3 Market Attractive Analysis By Product Service 2019
Chapter 6. Contract Development Service Market By Product
6.1 Introduction
6.2 Global Contract Development Service Revenue (US$ Mn) by Product
6.2.1 Global Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
6.2.2 MABs
6.2.2.1 MABs Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.3 Recombinant proteins
6.2.3.1 Recombinant proteins Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.4 Others
6.2.4.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.3 Market Attractive Analysis By Product 2019
Chapter 7. Contract Development Service Market By Disease
7.1 Introduction
7.2 Global Contract Development Service Revenue (US$ Mn) by sales Channel
7.2.1 Global Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 – 2027
7.2.2 Oncology
7.2.2.1 Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.3 Immunological Disorders
7.2.3.1 Immunological Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.4 Cardiovascular disorders
7.2.4.1 Cardiovascular disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.5 Hematological disorders
7.2.5.1 Hematological disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.6 Others
7.2.6.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.3 Market Attractive Analysis By Disease 2019
Chapter 8. North America Contract Development Service Market By Country
8.1 North America Contract Development Service Market Overview
8.2 U.S.
8.2.1 U.S. Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
8.2.2 U.S. Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
8.2.3 U.S. Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.2.4 U.S. Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
8.3 Canada
8.3.1 Canada Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
8.3.2 Canada Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
8.3.3 Canada Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.3.4 Canada Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
8.4 North America PEST Analysis
Chapter 9. Europe Contract Development Service Market By Country
9.1 Europe Contract Development Service Market Key Overview
9.2 UK
9.2.1 UK Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
9.2.2 UK Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
9.2.3 UK Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.4 UK Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
9.3 Germany
9.3.1 Germany Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
9.3.2 Germany Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
9.3.3 Germany Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.4 Germany Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
9.4 France
9.4.1 France Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
9.4.2 France Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
9.4.3 France Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.4 France Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
9.5 Spain
9.5.1 Spain Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
9.5.2 Spain Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
9.5.3 Spain Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.4 Spain Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
9.6 Rest of Europe
9.6.1 Rest of Europe Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
9.6.2 Rest of Europe Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
9.6.3 Rest of Europe Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.4 Rest of Europe Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
9.7 Europe PEST Analysis
Chapter 10. Asia-Pacific Contract Development Service Market By Country
10.1 Asia Pacific Contract Development Service Market Overview
10.2 China
10.2.1 China Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.2.2 China Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.2.3 China Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.4 China Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.3 Japan
10.3.1 Japan Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.3.2 Japan Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.3.3 Japan Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.4 Japan Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.4 India
10.4.1 India Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.4.2 India Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.4.3 India Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.4 India Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.5 Australia
10.5.1 Australia Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.5.2 Australia Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.5.3 Australia Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.5.4 Australia Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.6 South Korea
10.6.1 South Korea Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.6.2 South Korea Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.6.3 South Korea Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.6.4 South Korea Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.7 Rest of Asia-Pacific
10.7.1 Rest of Asia Pacific Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.7.2 Rest of Asia Pacific Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
10.7.3 Rest of Asia Pacific Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.7.4 Rest of Asia Pacific Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
10.8 Asia Pacific PEST Analysis
Chapter 11. Latin America Contract Development Service Market By Country
11.1 Latin America Contract Development Service Market Overview
11.2 Brazil
11.2.1 Brazil Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
11.2.2 Brazil Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
11.2.3 Brazil Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.4 Brazil Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
11.3 Mexico
11.3.1 Mexico Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
11.3.2 Mexico Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
11.3.3 Mexico Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.4 Mexico Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
11.4 Rest of Latin America
11.4.1 Rest of Latin America Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
11.4.2 Rest of Latin America Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
11.4.3 Rest of Latin America Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.4 Rest of Latin America Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
11.5 Latin America PEST Analysis
Chapter 12. Middle East & Africa Contract Development Service Market By Country
12.1 Middle East & Africa Contract Development Service Market Overview
12.2 Saudi Arabia
12.2.1 Saudi Arabia Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.2.2 Saudi Arabia Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
12.2.3 Saudi Arabia Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.2.4 Saudi Arabia Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
12.3 UAE
12.3.1 UAE Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.3.2 UAE Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
12.3.3 UAE Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.3.4 UAE Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
12.4 Rest of Middle East & Africa
12.4.1 Rest of Middle East & Africa Contract Development Service Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.4.2 Rest of Middle East & Africa Contract Development Service Market Revenue (US$ Mn) and Forecast By Product Service, 2016 - 2027
12.4.3 Rest of Middle East & Africa Contract Development Service Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.4.4 Rest of Middle East & Africa Contract Development Service Market Revenue (US$ Mn) and Forecast By Disease , 2016 - 2027
12.5 Middle East & Africa PEST Analysis
Chapter 13. Player Analysis of Contract Development Service
13.1 Global Contract Development Service Market Company Share Analysis
13.2 Competition Matrix
13.2.1 Mergers And Acquisition In Global Contract Development Service Market
Chapter 14. Company Profile
14.1 WuXi Biologics
14.1.1 Company Snapshot
14.1.2 Business Overview
14.1.3 Financial Overview
14.1.3.1 Revenue (US$ Mn), 2019
14.1.3.2 WuXi Biologics 2019 Contract Development Service Business Regional Distribution
14.1.4 Product/Service and Specifications
14.1.5 Recent Development & Business Strategy
14.1.6 Manufacturing Plant Footprint Analysis
14.2 Abzena Ltd.
14.3 Fujifilm Diosynth Biotechnologies
14.4 KBI Biopharma
14.5 AGC Biologics
14.6 SE Thermo Fisher
14.7 LakePharma
14.8 Genscript Biotech Corporation
14.9 Bionova Scientific
14.10 Boehringer Ingelheim BioXcellence
14.11 Others
![Contract Development Service Market (By Source: Microbial, Mammalian, Others; By Product Service: Cell Line Development, Process Development [Upstream, Downstream]; By Product: MABs, Recombinant proteins, Others; By Diseases: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027](assets/images/format-png.png "Contract Development Service Market (By Source: Microbial, Mammalian, Others; By Product Service: Cell Line Development, Process Development [Upstream, Downstream]; By Product: MABs, Recombinant proteins, Others; By Diseases: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027")
